Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
If they want a less expensive compounded version of these medications, semaglutide costs less per month (on average $400-$500) whereas trizepatide is approximately $600 per month
Table 8: Results at Week 26 in a Trial Comparing TRESIBA to Insulin Detemir in Pediatric Patients 1 Year of Age and Older with Type 1 Diabetes Mellitus Receiving Insulin Aspart at Mealtimes Type 2 Diabetes Adult Study D TRESIBA Administered at the Same Time Each Day as an Add on to Metformin with or without a DPP 4 Inhibitor in Insulin Nave Adult Patients The efficacy of TRESIBA was evaluated in a 52 week randomized, open label, multicenter trial that enrolled 1030 insulin nave patients with type 2 diabetes mellitus inadequately controlled on one or more oral antidiabetic agents (OADs)
Dabigatran (after 510 days parenteral)
Product intended for adults
US$ 21.11
US$ 20.94
US$ 27.98
